Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-19-001275
Filing Date
2019-02-13
Accepted
2019-02-13 12:02:13
Documents
1
Period of Report
2019-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_155007731792066.html 3  
1 FORM 3 wf-form3_155007731792066.xml 3 31909
  Complete submission text file 0001628280-19-001275.txt   33480
Mailing Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477
Business Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Issuer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2860 Industrial Organic Chemicals

Mailing Address KERYX BIOPHARMACEUTICALS, INC. 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address (212) 531-5965
Tarnok Michael P. (Reporting) CIK: 0001413525 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55264 | Film No.: 19595052